Literature DB >> 947550

A unique pattern of integrated viral genes in hamster cells transformed by highly oncogenic human adenovirus 12.

M R Green, G Chinnadurai, J K Mackey, M Green.   

Abstract

We have analyzed the viral DNA sequences persisting in HE C19, a clonal line of hamster embryo cells transformed in vitro by human adenovirus 12 (Ad 12), a member of highly oncogenic group A. Saturation-hybridization of in vitro labeled Ad 12 DNA (2-4 x 10(8) cpm/mug) with HE C19 DNA showed that 93-100% of viral DNA sequences are present in the transformed cell. Reassociation of Ad 12 32P-DNA in the presence of HE C19 DNA detected 8 viral genome equivalents per diploid quantity of cell DNA. REannealing each of the six Ad 12 EcoRl restriction DNA fragments with HE C19 DNA indicated that the sequences of each fragment are present in near equimolar quantities, 8-10.5 copies per cell. HE C19 DNA "networks" were prepared and shown to contain the same viral DNA sequences and in the same amounts as present in unfractionated transformed cell DNA; these data provide the first direct evidence that human adenovirus genes are covalently linked to cellular DNA. The presence of most, if not all, of the viral genes was demonstrated also in the Ad 12 hamster tumor cell line, HT-2. The pattern of integrated viral genes in these nonpermissive hamster cells transformed by Ad 12 is different from that described for cells transformed by group C and B human adenoviruses and for SV40.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947550     DOI: 10.1016/0092-8674(76)90172-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  22 in total

1.  Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups.

Authors:  M Green; K Brackmann; W S Wold; M Cartas; H Thornton; J H Elder
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Human adenovirus type 9-induced rat mammary tumors.

Authors:  R Javier; K Raska; G J Macdonald; T Shenk
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

3.  Some adenovirus DNA is associated with the DNA of permissive cells during productive or restricted growth.

Authors:  C Tyndall; H B Younghusband; A J Bellett
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

4.  Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences.

Authors:  W S Wold; J K Mackey; K H Brackmann; N Takemori; P Rigden; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  Adenovirus type 12 DNA sequences in primary hamster tumors.

Authors:  K C Lee; S Mak
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

6.  mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells.

Authors:  G Chinnadurai; H M Rho; R B Horton; M Green
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

7.  Transcription of the genome of adenovirus type 12. III. Maps of stable RNA from productively infected human cells and abortively infected and transformed hamster cells.

Authors:  J Ortin; K H Scheidtmann; R Greenberg; M Westphal; W Doerfler
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

8.  Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli.

Authors:  L A Lucher; D Kimelman; J S Symington; K H Brackmann; M A Cartas; H Thornton; M Green
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines.

Authors:  J L Whittaker; P J Byrd; R J Grand; P H Gallimore
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

10.  Integration sites of adenovirus type 12 DNA in transformed hamster cells and hamster tumor cells.

Authors:  S Stabel; W Doerfler; R R Friis
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.